Don Jung
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Cancer-related Molecular Pathways, Aldose Reductase and Taurine, Epigenetics and DNA Methylation, Cancer Research and Treatments
Most-Cited Works
- → Potent and Highly Selective Hypoxia-Activated Achiral Phosphoramidate Mustards as Anticancer Drugs(2008)237 cited
- → Assessing Shared Leadership: Development and Preliminary Validation of a Team Multifactor Leadership Questionnaire(2003)97 cited
- → Educational Curricula and Self-Efficacy: Entrepreneurial Orientation and New Venture Intentions among University Students in Mexico(2006)48 cited
- → Pharmacokinetics of Mycophenolate Mofetil and Intravenous Ganciclovir Alone and in Combination in Renal Transplant Recipients(1997)35 cited
- → Comparison of hypoxia-activated prodrug evofosfamide (TH-302) and ifosfamide in preclinical non-small cell lung cancer models(2016)26 cited
- → Discovery of TH-302: An achiral hypoxia-activated cytotoxic prodrug(2007)4 cited
- Phase I trial of glycolitic inhibition with 2-deoxyglucose and docetaxel for patients with solid tumors(2006)
- → A Novel PBPK Modeling Approach to Assess Cytochrome P450 Mediated Drug‐Drug Interaction Potential of the Cytotoxic Prodrug Evofosfamide(2018)3 cited
- → Enhanced pharmacological activities of AKR1C3‐activated prodrug AST‐3424 in cancer cells with defective DNA repair(2024)2 cited
- → Abstract 1369: In vitro and in vivo antitumor activity of TH3424: Preclinical rationale for a highly selective AKR1C3 prodrug for treating hepatocellular carcinomas(2016)1 cited